Skip Navigation
< Back
QualityTool

American Society of Clinical Oncology (ASCO) Patient Guide: HER2 Testing for Breast Cancer


Description

This educational guide provides patients with information about the American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer. 

The guide includes the following sections:

  • Background
  • Recommendations
  • What this means for patients
  • Questions to ask the doctor
  • Helpful links

Developer

American Society of Clinical Oncology; College of American Pathologists

Funding Sources

American Society of Clinical Oncology; College of American Pathologists


QualityTool Topic

Disease/Condition-Related; Guideline-Related


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer:
http://www.guideline.gov/summary/summary.aspx?doc_id=10384

History

  • Release Date: 12/2006
  • Original Summary: 06/2007
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification

Disease/Clinical Category:
Patient Population:
Stage of Care:
IOM Domains of Quality:
QualityTool Format:

Last updated: March 07, 2012.